Patent details

EP3056200 Title: HUPERZINE FOR USE IN TREATING SEIZURE

Basic Information

Publication number:
EP3056200
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP160007415
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HUPERZINE FOR USE IN TREATING SEIZURE
French Title of Invention:
HUPERZINE POUR SON UTILISATION DANS LE TRAITEMENT D'UNE ATTAQUE
German Title of Invention:
HUPERZIN ZUR VERWENDUNG IN DER BEHANDLUNG VON EINEM ANFALL
SPC Number:

Dates

Filing date:
23/05/2006
Grant date:
06/09/2023
EP Publication Date:
17/08/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/09/2023
EP B1 Publication Date:
06/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/05/2024
Expiration date:
23/05/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/08/2023
 
 

Name:
President and Fellows of Harvard College
Address:
17 Quincy Street, Cambridge, MA 02138, United States (US)

Inventor

Name:
Schachter, Steven, C.
Address:
United States (US)

Priority

1

Priority Number:
683745 P
Priority Date:
23/05/2005
Priority Country:
United States (US)

2

Priority Number:
756141 P
Priority Date:
04/01/2006
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/215; A61K 31/74; A61K 9/20; A61P 25/08; A61P 25/00; A61P 29/00; A61P 19/02; A61P 25/02; A61K 31/473; A61K 31/4745;

Publication

European Patent Bulletin

Issue number:
202336
Publication date:
06/09/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages